{"id":936,"date":"2024-05-29T09:00:52","date_gmt":"2024-05-29T08:00:52","guid":{"rendered":"https:\/\/beigen.vipdev.lndo.site\/?p=936"},"modified":"2025-05-28T11:22:12","modified_gmt":"2025-05-28T09:22:12","slug":"tislelizumab-moa-video","status":"publish","type":"post","link":"https:\/\/beonemedaffairs.com\/us\/936\/tislelizumab-moa-video\/","title":{"rendered":"Tislelizumab MoA video"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":17,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"editor_notices":[],"footnotes":""},"categories":[5],"post-tag":[645,585,648,588,570,571,637,638,646,586,694,568,636,676,700,46,696,538],"specialisation":[],"class_list":["post-936","post","type-post","status-publish","format-standard","hentry","category-video","post-tag-chl","post-tag-classical-hodgkins-lymphoma","post-tag-escc","post-tag-esophageal-squamous-cell-carcinoma","post-tag-gastric-cancer","post-tag-gastroesophageal-junction-cancer","post-tag-gc","post-tag-gejc","post-tag-hcc","post-tag-hepatocellular-carcinoma","post-tag-moa","post-tag-non-small-cell-lung-cancer","post-tag-nsclc","post-tag-pd-1","post-tag-pd-l1","post-tag-solid-tumor","post-tag-tislelizumab-moa","post-tag-tislelizumab"],"acf":{"visible_for_guests":false,"title":"Tislelizumab MoA","card_title":"Tislelizumab MoA","title_for_guests":"","summary":"Tislelizumab (BGB-A317) is a humanized IgG4 monoclonal antibody designed to bind and inhibit PD\u20111. Watch the mode of action (MoA) video to learn more.","card_summary":"Tislelizumab (BGB-A317) is a humanized IgG4 monoclonal antibody designed to bind and inhibit PD\u20111. Watch the mode of action (MoA) video to learn more.","summary_for_guests":"","show_popup_window_to_guests":true,"blur_thumbnail_for_guests":true,"text_app":"","text":"","content-type":5,"download_file_reading":null,"display_file_reading":null,"download_file_slidekit":null,"display_file_slidekit":null,"3qsdn":"a50d44a8-2329-422c-9310-e090586434ae","motionposter":false,"webcast":"","videolange":"22:04:00","fliphtml_link":"","authors":"","specialisation":[],"tags":[538,694,676,588,648,586,646,568,636,585,645,700,570,637,571,638,46,696],"visible_tags":[538,694,676],"post_image":7227,"post_image_for_guests":"","related_posts":[{"id":6749,"title":"BGB-16673 MoA","title_guest":"","summary":"BGB-16673 is an investigational chimeric degradation activating compound (CDAC) targeting BTK. Watch the mechanism of action video (MoA) to learn more.","summary_guest":"","content-type":5,"post_image":7224,"blur_thumbnail_guest":false,"post_image_guest":false,"videolange":"22:02:57","url":"https:\/\/beonemedaffairs.com\/us\/6749\/bgb-16673-moa\/","date":"2024-12-04T16:31:45","date_gmt":"2024-12-04T15:31:45"},{"id":6740,"title":"Quick Reference Guide for Solid Tumors","title_guest":"","summary":"","summary_guest":"","content-type":4,"post_image":6741,"blur_thumbnail_guest":false,"post_image_guest":false,"videolange":null,"url":"https:\/\/beonemedaffairs.com\/us\/6740\/quick-reference-guide-for-solid-tumors\/","date":"2024-12-04T16:29:46","date_gmt":"2024-12-04T15:29:46"},{"id":6263,"title":"Interactive BeiGene Pipeline Tool","title_guest":"","summary":"Browse BeiGene\u2019s interactive pipeline of oral small molecules and monoclonal antibodies to treat cancer.","summary_guest":"","content-type":4,"post_image":6449,"blur_thumbnail_guest":false,"post_image_guest":false,"videolange":null,"url":"https:\/\/beonemedaffairs.com\/us\/6263\/interactive-development-program\/","date":"2024-08-31T09:00:42","date_gmt":"2024-08-31T07:00:42"},{"id":6353,"title":"Zanubrutinib MoA","title_guest":"","summary":"Zanubrutinib is a next-generation Bruton\u2019s tyrosine kinase inhibitor (BTKi) designed for selectivity, potency, and bioavailability. Watch the mode of action (MoA) video to learn more.","summary_guest":"","content-type":5,"post_image":7226,"blur_thumbnail_guest":false,"post_image_guest":false,"videolange":"22:02:26","url":"https:\/\/beonemedaffairs.com\/us\/6353\/zanubrutinib-moa-video\/","date":"2024-05-29T09:00:54","date_gmt":"2024-05-29T07:00:54"}]},"_links":{"self":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/posts\/936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/comments?post=936"}],"version-history":[{"count":18,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/posts\/936\/revisions"}],"predecessor-version":[{"id":7243,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/posts\/936\/revisions\/7243"}],"acf:term":[{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/696"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/46"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/638"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/571"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/637"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/570"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/700"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/645"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/585"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/636"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/568"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/646"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/586"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/648"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/588"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/676"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/694"},{"embeddable":true,"taxonomy":"post-tag","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag\/538"},{"embeddable":true,"taxonomy":"category","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/categories\/5"}],"wp:attachment":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/media?parent=936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/categories?post=936"},{"taxonomy":"post-tag","embeddable":true,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag?post=936"},{"taxonomy":"specialisation","embeddable":true,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/specialisation?post=936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}